Evolus EOLS
NASDAQ EOLS
$7.99 +0.03 (+0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Evolus (EOLS) Restructuring Costs (2020 - 2025)

Updated

Evolus' Restructuring Costs was $1.44 million in FY2025.

Analysis

Evolus (EOLS) Restructuring Costs (2020 - 2025) Analysis & Trends

  • Restructuring Costs shows a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
  • The FY2025 figure marks the highest annual Restructuring Costs since FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Evolus 525.47 Mn 333.16 Mn 57.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.44 Mn
Jun 30, 2020 2.96 Mn
API Access

Evolus Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=EOLS&period=max&api_key=YOUR_API_KEY